CA19-9 Decrease and Kinetics in a Randomized Phase III Trial (MPACT) of Weekly Nab-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer

Autor:	Ramesh K. Ramanathan, Josep Tabernero, Francis P. Arena, Philip Clingan, Thomas Ervin, Daniel D. Von Hoff, Jeffrey R. Infante, Elena G. Chiorean, Venu Bathini, Volker Kunzmann, Michele Reni, David Goldstein, Amy Ko, Brian Lu
Rok vydání:	2013
Předmět:	Oncology medicine.medical_specialty business.industry Kinetics Hematology Gemcitabine Paclitaxel protein-bound Internal medicine Metastatic pancreatic cancer medicine business medicine.drug Nab-paclitaxel
Zdroj:	Annals of Oncology. 24:iv31
ISSN:	0923-7534
DOI:	10.1093/annonc/mdt202.19
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::891fa84011703e3e9312ae7d1d714e1d https://doi.org/10.1093/annonc/mdt202.19 Zobrazit plný text záznamu